Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
Marlou J JongkeesNgoc H TanDaryl GeersRory D de VriesCorine H GeurtsvanKesselKathryn S HensleyRoos S G SablerollesSusanne BogersLennert GommersBlerdi BlakajPedro Miranda AfonsoBettina E HansenBart J A RijndersKees BrinkmanP Hugo M van der KuyAnna H E RoukensCasper RokxPublished in: AIDS (London, England) (2024)
A bivalent BA.1 booster vaccine was immunogenic in well treated PWH, eliciting comparable humoral responses to non-PWH. However, T-cell responses waned faster after 90 days in PWH compared to non-PWH.